These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38000211)

  • 1. Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics.
    Zhu Z; Tang W; Qiu X; Xin X; Zhang J
    Eur J Med Chem; 2024 Jan; 263():115967. PubMed ID: 38000211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in phosphodiesterase activity in the developing rat submandibular gland.
    Tanaka S; Shimooka S; Shimomura H
    Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors.
    Xia Y; Chackalamannil S; Czarniecki M; Tsai H; Vaccaro H; Cleven R; Cook J; Fawzi A; Watkins R; Zhang H
    J Med Chem; 1997 Dec; 40(26):4372-7. PubMed ID: 9435906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.
    Kim GE; Kass DA
    Handb Exp Pharmacol; 2017; 243():249-269. PubMed ID: 27787716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase inhibition in heart failure.
    Movsesian M; Stehlik J; Vandeput F; Bristow MR
    Heart Fail Rev; 2009 Dec; 14(4):255-63. PubMed ID: 19096931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.
    Wennogle LP; Hoxie H; Peng Y; Hendrick JP
    Adv Neurobiol; 2017; 17():349-384. PubMed ID: 28956339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects.
    Huang MX; Tian YJ; Han C; Liu RD; Xie X; Yuan Y; Yang YY; Li Z; Chen J; Luo HB; Wu Y
    J Med Chem; 2022 Jun; 65(12):8444-8455. PubMed ID: 35666471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PDE1-encoded low-affinity phosphodiesterase in the yeast Saccharomyces cerevisiae has a specific function in controlling agonist-induced cAMP signaling.
    Ma P; Wera S; Van Dijck P; Thevelein JM
    Mol Biol Cell; 1999 Jan; 10(1):91-104. PubMed ID: 9880329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.
    Hashimoto T; Kim GE; Tunin RS; Adesiyun T; Hsu S; Nakagawa R; Zhu G; O'Brien JJ; Hendrick JP; Davis RE; Yao W; Beard D; Hoxie HR; Wennogle LP; Lee DI; Kass DA
    Circulation; 2018 Oct; 138(18):1974-1987. PubMed ID: 30030415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional plasticity of cyclic AMP hydrolysis in rat adenohypophysial corticotroph cells.
    Ang KL; Antoni FA
    Cell Signal; 2002 May; 14(5):445-52. PubMed ID: 11882389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of cyclic nucleotide phosphodiesterases PDE1A, existing as a stable complex with calmodulin, and PDE3A in human spermatozoa.
    Lefièvre L; de Lamirande E; Gagnon C
    Biol Reprod; 2002 Aug; 67(2):423-30. PubMed ID: 12135876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
    Kokkonen K; Kass DA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
    J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Ca2+/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms.
    Spence S; Rena G; Sweeney G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):975-82. PubMed ID: 7575435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cyclic AMP phosphodiesterase 4 isoenzyme inhibitory activity of heterocycle condensed purines.
    Suzuki H; Yamamoto M; Shimura S; Miyamoto K; Yamamoto K; Sawanishi H
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1163-8. PubMed ID: 12237530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose exerts opposite effects on mRNA versus protein and activity levels of Pde1, the low-affinity cAMP phosphodiesterase from budding yeast, Saccharomyces cerevisiae.
    Wera S; Ma P; Thevelein JM
    FEBS Lett; 1997 Dec; 420(2-3):147-50. PubMed ID: 9459299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indoles: discovery of potent, selective phosphodiesterase type 4 inhibitors.
    Burnouf C; Auclair E; Avenel N; Bertin B; Bigot C; Calvet A; Chan K; Durand C; Fasquelle V; Féru F; Gilbertsen R; Jacobelli H; Kebsi A; Lallier E; Maignel J; Martin B; Milano S; Ouagued M; Pascal Y; Pruniaux MP; Puaud J; Rocher MN; Terrasse C; Wrigglesworth R; Doherty AM
    J Med Chem; 2000 Dec; 43(25):4850-67. PubMed ID: 11123995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.